An end is drawing close for Illumina’s multibillion-dollar pursuit of Grail. The...
According to the FDA, the current dominant strain of COVID-19 should be a key fo...
In a follow-up study conducted on approximately 160 people, it was discovered th...
The government of Victoria in Australia announced that a highly virulent variant...
Soterios Pharma plans to proceed to phase 3 trials after its 1% Alopecia areata ...
Scientists have discovered a new antibiotic derived from AstraZeneca drugs that ...
Akili Interactive, a firm that develops medical applications, announced earlier ...
The U.S. Food and Drug Administration has approved Bkemv by Amgen, the first bio...
When compared to docetaxel, the TROPION-Lung01 Phase III trial indicated that da...
Globally, hundreds of millions of poultry have lost their lives to bird flu, or ...
According to the information on the clinical trials database maintained by the U...
Johnson & Johnson developed seltorexant as an orexin-2 antagonist to prevent exc...
In a bid to venture into the healthcare field from its domain in the industrial ...
Gerresheimer, the maker of innovative systems and solutions and a partner to the...
Daiichi Sankyo and AstraZeneca have applied to the FDA for their second-generati...
Neuren Pharmaceuticals revealed key outcomes from its Phase 2 study of NNZ-2591 ...
